Optimizing Hydroxyurea Dosing in Sickle Cell Anemia: The Uganda MTD Study

被引：5
|
作者：
John, Chandy C. [1 ]
Opoka, Robert [2 ]
Latham, Teresa [3 ]
Hume, Heather [4 ,5 ]
Nakafeero, Maria [6 ]
Kasirye, Phillip [7 ]
Ndugwa, Christopher [8 ]
Lane, Adam [3 ]
Ware, Russell E. [9 ,10 ]
机构：
[1] Indiana Univ, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46204 USA
[2] Makerere Univ, Pediat & Child Hlth, Kampala, Uganda
[3] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Cincinnati, OH 45229 USA
[4] CHU St Justine, Dept Pediat, Montreal, PQ, Canada
[5] Makerere Univ, Coll Hlth Sci, Kampala, Uganda
[6] Global Hlth Uganda, Kampala, Uganda
[7] Mulago Natl Referral Hosp, Kampala, Uganda
[8] Makerere Univ, Kampala, Uganda
[9] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[10] Cincinnati Childrens Hosp Med Ctr, Global Hlth Ctr, Cincinnati, OH 45229 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-125128
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
520
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Optimizing hydroxyurea therapy for sickle cell anemia
    Ware, Russell E.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 436 - 443
  • [2] Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen
    Ines Paule
    Hind Sassi
    Anoosha Habibi
    Kim PD Pham
    Dora Bachir
    Frédéric Galactéros
    Pascal Girard
    Anne Hulin
    Michel Tod
    Orphanet Journal of Rare Diseases, 6
  • [3] Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen
    Paule, Ines
    Sassi, Hind
    Habibi, Anoosha
    Pham, Kim P. D.
    Bachir, Dora
    Galacteros, Frederic
    Girard, Pascal
    Hulin, Anne
    Tod, Michel
    ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
  • [4] Hydroxyurea reduces infections in children with sickle cell anemia in Uganda
    Namazzi, Ruth
    Bond, Caitlin
    Conroy, Andrea L.
    Datta, Dibyadyuti
    Tagoola, Abner
    Goings, Michael J.
    Jang, Jeong Hoon
    Ware, Russell E.
    Opoka, Robert
    John, Chandy C.
    BLOOD, 2024, 143 (14) : 1425 - 1428
  • [5] Intensive hydroxyurea dosing in very young children with sickle cell anemia
    Wang, Winfred C.
    Brown, R. Clark
    Mcnaull, Melissa A.
    Rogers, Zora R.
    Barton, Martha
    Dua, Meghna R.
    Hankins, Jane S.
    Gossett, Jeffrey
    Richardson, Julie
    Porter, Jerlym S.
    Kang, Guolian
    Estepp, Jeremie H.
    BLOOD ADVANCES, 2023, 7 (22) : 6931 - 6935
  • [6] Hydroxyurea for sickle cell anemia
    Bachmeyer, Claude
    Aractingi, Selim
    Lionnet, Francois
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (01): : 98 - 98
  • [7] THE FEASIBILITY OF PHARMACOKINETIC-GUIDED HYDROXYUREA DOSING FOR CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA: ANALYSIS OF THE ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT) TRIAL
    Power-Hays, A.
    Namazzi, R.
    Kazinga, C.
    Mufumba, I.
    Latham, T.
    Conroy, A.
    Opoka, R.
    Vinks, A.
    Dong, M.
    Ware, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S58 - S58
  • [8] Design of the multicenter study of hydroxyurea in sickle cell anemia
    Charache, S
    Terrin, ML
    Moore, RD
    Dover, GJ
    McMahon, RP
    Barton, FB
    Waclawiw, M
    Eckert, SV
    CONTROLLED CLINICAL TRIALS, 1995, 16 (06): : 432 - 446
  • [9] Hydroxyurea marketed for sickle cell anemia
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (09) : 875 - 875
  • [10] Hydroxyurea for the treatment of sickle cell anemia
    Platt, Orah S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (13): : 1362 - 1369
12345